Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-24-003595
Filing Date
2024-04-29
Accepted
2024-04-29 11:20:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 30875
2 GRAPHIC g803738dsp22.jpg GRAPHIC 7814
  Complete submission text file 0000950123-24-003595.txt   42734
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)